Prothena Reports Third Quarter 2017 Financial Results and Provides R&D Update

Go back to Prothena Reports Third Quarter 2017 Financial Results and Provides R&D Update

Prothena Corp. (PRTA) Tops Q3 EPS by 2c

November 7, 2017 4:50 PM EST

Prothena Corp. (NASDAQ: PRTA) reported Q3 EPS of ($1.37), $0.02 better than the analyst estimate of ($1.39). Revenue for the quarter came in at $219 thousand versus the consensus estimate of $250 thousand.

Net cash used in operating and investing activities was $18.3 million in the third quarter and... More